1. Home
  2. NSRX vs CPHI Comparison

NSRX vs CPHI Comparison

Compare NSRX & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.09

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$0.69

Market Cap

41.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSRX
CPHI
Founded
2019
N/A
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
41.3M
IPO Year
2024
2008

Fundamental Metrics

Financial Performance
Metric
NSRX
CPHI
Price
$3.09
$0.69
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $19.67
N/A
AVG Volume (30 Days)
21.1K
★ 3.9M
Earning Date
08-17-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.98
$0.38
52 Week High
$9.50
$19.19

Technical Indicators

Market Signals
Indicator
NSRX
CPHI
Relative Strength Index (RSI) 34.65 45.83
Support Level $2.97 $0.53
Resistance Level $3.60 $0.91
Average True Range (ATR) 0.25 0.15
MACD -0.07 0.01
Stochastic Oscillator 10.94 15.90

Price Performance

Historical Comparison
NSRX
CPHI

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: